Lipid levels in serum and cancerous tissues of colorectal cancer patients

Table 3 Correlations between serum lipid levels and cancerous tissue of patients with colorectal cancer with the tumor node metastasis stages

Groups	Case (n)	TCH	FCH	TG	HDL-C	LDL-C
Tissue (μmol/g)
I	15	18.3 ± 4.2	14.4 ± 8.3	17.2 ± 10.9	5.1 ± 4.3	3.9 ± 2.3
II	66	17.9 ± 3.6	15.2 ± 9.7	16.5 ± 12.2	5.7 ± 3.6	4.2 ± 2.9
III	53	16.3 ± 4.0	15.9 ± 13.4	14.9 ± 13.3	7.2 ± 5.2	4.5 ± 3.4
IV	18	13.5 ± 5.3a	13.1 ± 9.2	13.4 ± 9.4a	9.3 ± 3.2a	4.2 ± 2.7
Serum (mmol/L)
I	25	5.9 ± 0.8	1.5 ± 0.2	2.8 ± 1.1	1.5 ± 0.4	3.5 ± 1.3
II	113	4.8 ± 0.9	1.4 ± 0.3	1.9 ± 0.7	1.4 ± 0.3	3.1 ± 0.9
III	91	4.1 ± 1.0	1.4 ± 0.4	1.5 ± 0.9	1.4 ± 0.3	3.0 ± 0.9
IV	31	3.9 ± 0.9d	1.3 ± 0.4	1.3 ± 0.5d	1.1 ± 0.6	3.0 ± 0.8

^aP < 0.05 vs the levels of total cholesterol (TCH) and high density lipoprotein-cholesterol (HDL-C) in cancerous tissues with tumor node metastasis (TNM) stages;

^dP < 0.01 vs the levels of TCH and triglyceride (TG) in serum with TNM stages. LDL-C: Low density lipoprotein-cholesterol.